Answers are grounded in this paper and cite their sources.
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in COVID-19 patients, especially when administered early after diagnosis. Here, we discuss the successes and challenges of COVID-19 antiviral therapies and lessons for future pandemics.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: